Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Sartorius Stedim Biotech    DIM   FR0013154002

SARTORIUS STEDIM BIOTECH

(DIM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Sartorius Stedim Biotech SA: Notification of transactions made by persons discharging managerial responsibilities and persons closely related to them

11/02/2020 | 12:30pm EST

Sartorius Stedim Biotech SA
Sartorius Stedim Biotech SA: Notification of transactions made by persons discharging managerial responsibilities and persons closely related to them

02-Nov-2020 / 18:30 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


 

Notification of transactions made by persons discharging managerial responsibilities and persons closely related to them

 

 

1. Contact information for the person discharging managerial responsibilities or the closely related person

 

Company name: Sartorius AG

Legal form: AG (Aktiengesellschaft)

 

2. Reason for notification

 

The declarant is a closely related person referred to in Article 3.26) of EU Regulation 596/2014 of April 16, 2014 on market abuse.

 

Please specify the positions held within the issuer.

 

Positions:  i. Joachim Kreuzburg is chairman and CEO of Sartorius Stedim Biotech SA and chairman of the management board of Sartorius AG;

ii. Dr. René Fáber is a member of the board of Sartorius Stedim Biotech SA and a member of the management board of Sartorius AG;

iii. Dr. Lothar Kappich is a member of the board of Sartorius Stedim Biotech SA and chairman of the supervisory board of Sartorius AG.

 

This is an initial notification.

 

3. Contact information of the issuer

 

Company name: Sartorius Stedim Biotech S.A.

LEI: 52990006IVXY7GCSSR39

 

4. Information about the transaction

 

Date of the transaction: 02/11/2020

Place of the transaction: outside a trading venue

Nature of the transaction: sale

Description of the financial instrument: shares

Identification code: FR0013154002

 

Detailed information by transaction:

Unit price: EUR 327.00

Volume: 405,887 shares

 

Aggregated information:

Weighted average price: EUR 327.00

Volume: 405,887 shares

 

The transaction is NOT related to the exercise of a stock option program or to a bonus or performance share grant.

 

5. Comments

 

Ø


Regulatory filing PDF file

File: Notification of transactions made by persons discharging managerial responsibilities and persons closely related to them


Language: English
Company: Sartorius Stedim Biotech SA
Avenue de Jouques
13781 Aubagne
France
Phone: +33 44 284 5600
E-mail: info@sartorius-stedim.com
Internet: www.sartorius-stedim.com
ISIN: FR0013154002
Euronext Ticker: DIM
AMF Category: Inside information / Other releases
EQS News ID: 1144863
 
End of Announcement EQS News Service

1144863  02-Nov-2020 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1144863&application_name=news&site_id=zonebourse_sftp

© EQS 2020
All news about SARTORIUS STEDIM BIOTECH
01/15SARTORIUS STEDIM BIOTECH : Partners With RoosterBio to Advance Cell and Gene...
PU
01/06SARTORIUS STEDIM BIOTECH : to acquire Novasep's chromatography...
PU
01/05SARTORIUS STEDIM BIOTECH : Annual Report 2020 of the Liquidity Contract with the..
PU
01/05SARTORIUS STEDIM BIOTECH SA : Bilan SEMESTRIEL S2 -3-
DJ
01/05SARTORIUS STEDIM BIOTECH SA : Bilan SEMESTRIEL S2 -2-
DJ
01/05SARTORIUS STEDIM BIOTECH SA : Bilan SEMESTRIEL S2 du contrat de liquidité contra..
DJ
01/05SARTORIUS STEDIM BIOTECH SA : Full-year report of -3-
DJ
01/05SARTORIUS STEDIM BIOTECH SA : Full-year report of -2-
DJ
01/05SARTORIUS STEDIM BIOTECH SA : Full-year report of the liquidity contract with th..
DJ
01/04SARTORIUS STEDIM BIOTECH SA : Declaration relative au nombre d'actions et de dro..
DJ
More news
Financials
Sales 2020 1 877 M 2 265 M 2 265 M
Net income 2020 342 M 412 M 412 M
Net Debt 2020 261 M 315 M 315 M
P/E ratio 2020 83,3x
Yield 2020 0,30%
Capitalization 28 576 M 34 549 M 34 468 M
EV / Sales 2020 15,4x
EV / Sales 2021 12,7x
Nbr of Employees 6 979
Free-Float 25,7%
Chart SARTORIUS STEDIM BIOTECH
Duration : Period :
Sartorius Stedim Biotech Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SARTORIUS STEDIM BIOTECH
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 8
Average target price 289,63 €
Last Close Price 310,00 €
Spread / Highest target 25,2%
Spread / Average Target -6,57%
Spread / Lowest Target -37,7%
EPS Revisions
Managers and Directors
NameTitle
Joachim Kreuzburg Chairman & Chief Executive Officer
Volker Niebel Executive VP-Operations & Information Technology
Oscar-Werner Reif Executive VP-Research & Development
Henri Riey Independent Non-Executive Director
Anne-Marie Graffin Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
SARTORIUS STEDIM BIOTECH6.46%34 549
ABBOTT LABORATORIES1.65%190 701
MEDTRONIC PLC-0.28%157 229
BECTON, DICKINSON AND COMPANY4.60%76 127
HOYA CORPORATION-2.24%50 041
ALIGN TECHNOLOGY, INC.6.15%44 726